{"count": 217, "results": [{"_id": "36552855", "pmid": 36552855, "pmcid": "PMC9777391", "title": "Deciphering the Antifibrotic Property of Metformin", "journal": "Cells", "authors": ["Septembre-Malaterre A", "Boina C", "Douanier A", "Gasque P"], "date": "2022-12-16T00:00:00Z", "doi": "10.3390/cells11244090", "meta_date_publication": "2022 Dec 16", "meta_volume": "11", "meta_issue": "24", "meta_pages": "", "score": 50275.793, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ is known to have antidiabetic properties but has never been tested in the context of an in vitro model of MSC-mediated @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@fibrosis@@@.", "citations": {"NLM": "Septembre-Malaterre A, Boina C, Douanier A, Gasque P. Deciphering the Antifibrotic Property of Metformin Cells. 2022 Dec 16;11(24):. PMID: 36552855", "BibTeX": "@article{36552855, title={Deciphering the Antifibrotic Property of Metformin}, author={Septembre-Malaterre A and Boina C and Douanier A and Gasque P}, journal={Cells}, volume={11}, number={24}}"}}, {"_id": "34007848", "pmid": 34007848, "pmcid": "PMC8102119", "title": "Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms", "journal": "J Diabetes Res", "authors": ["Wu M", "Xu H", "Liu J", "Tan X", "Wan S", "Guo M", "Long Y", "Xu Y"], "date": "2021-04-29T00:00:00Z", "doi": "10.1155/2021/6673525", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "6673525", "score": 50275.004, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@Fibrosis@@@: A Review of Existing Evidence and Mechanisms", "citations": {"NLM": "Wu M, Xu H, Liu J, Tan X, Wan S, Guo M, Long Y, Xu Y. Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms J Diabetes Res. 2021;2021():6673525. PMID: 34007848", "BibTeX": "@article{34007848, title={Metformin and Fibrosis: A Review of Existing Evidence and Mechanisms}, author={Wu M and Xu H and Liu J and Tan X and Wan S and Guo M and Long Y and Xu Y}, journal={J Diabetes Res}, volume={2021}, pages={6673525}}"}}, {"_id": "38114915", "pmid": 38114915, "pmcid": "PMC10731715", "title": "Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis", "journal": "BMC Gastroenterol", "authors": ["Huynh DJ", "Renelus BD", "Jamorabo DS"], "date": "2023-12-19T00:00:00Z", "doi": "10.1186/s12876-023-03085-8", "meta_date_publication": "2023 Dec 19", "meta_volume": "23", "meta_issue": "1", "meta_pages": "450", "score": 50271.914, "text_hl": "Our study demonstrates that using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and SGLT2-I is associated with reduced decompensated @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@cirrhosis@@@. ", "citations": {"NLM": "Huynh DJ, Renelus BD, Jamorabo DS. Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis BMC Gastroenterol. 2023 Dec 19;23(1):450. PMID: 38114915", "BibTeX": "@article{38114915, title={Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis}, author={Huynh DJ and Renelus BD and Jamorabo DS}, journal={BMC Gastroenterol}, volume={23}, number={1}, pages={450}}"}}, {"_id": "34502314", "pmid": 34502314, "pmcid": "PMC8430638", "title": "Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice", "journal": "Int J Mol Sci", "authors": ["Loi H", "Kramar S", "Laborde C", "Marsal D", "Pizzinat N", "Cussac D", "Roncalli J", "Boal F", "Tronchere H", "Oleshchuk O", "Korda M", "Kunduzova O"], "date": "2021-08-30T00:00:00Z", "doi": "10.3390/ijms22179393", "meta_date_publication": "2021 Aug 30", "meta_volume": "22", "meta_issue": "17", "meta_pages": "", "score": 50268.977, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Attenuates Postinfarction @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@Myocardial Fibrosis@@@ and @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@Inflammation@@@ in Mice", "citations": {"NLM": "Loi H, Kramar S, Laborde C, Marsal D, Pizzinat N, Cussac D, Roncalli J, Boal F, Tronchere H, Oleshchuk O, Korda M, Kunduzova O. Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice Int J Mol Sci. 2021 Aug 30;22(17):. PMID: 34502314", "BibTeX": "@article{34502314, title={Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice}, author={Loi H and Kramar S and Laborde C and Marsal D and Pizzinat N and Cussac D and Roncalli J and Boal F and Tronchere H and Oleshchuk O and Korda M and Kunduzova O}, journal={Int J Mol Sci}, volume={22}, number={17}}"}}, {"_id": "34434111", "pmid": 34434111, "pmcid": "PMC8381252", "title": "Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway", "journal": "Front Pharmacol", "authors": ["Li SX", "Li C", "Pang XR", "Zhang J", "Yu GC", "Yeo AJ", "Lavin MF", "Shao H", "Jia Q", "Peng C"], "date": "2021-08-09T00:00:00Z", "doi": "10.3389/fphar.2021.719589", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "719589", "score": 50266.36, "text_hl": "Evidence has shown that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ effects and anti-@<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@fibrosis@@@ effects. ", "citations": {"NLM": "Li SX, Li C, Pang XR, Zhang J, Yu GC, Yeo AJ, Lavin MF, Shao H, Jia Q, Peng C. Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway Front Pharmacol. 2021;12():719589. PMID: 34434111", "BibTeX": "@article{34434111, title={Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway}, author={Li SX and Li C and Pang XR and Zhang J and Yu GC and Yeo AJ and Lavin MF and Shao H and Jia Q and Peng C}, journal={Front Pharmacol}, volume={12}, pages={719589}}"}}, {"_id": "34381133", "pmid": 34381133, "pmcid": "PMC8357942", "title": "Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy", "journal": "Sci Rep", "authors": ["Wang F", "Sun H", "Zuo B", "Shi K", "Zhang X", "Zhang C", "Sun D"], "date": "2021-08-11T00:00:00Z", "doi": "10.1038/s41598-021-95827-5", "meta_date_publication": "2021 Aug 11", "meta_volume": "11", "meta_issue": "1", "meta_pages": "16362", "score": 50266.035, "text_hl": "The scavenging activity was significantly higher after 4 weeks of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment than after 12 weeks, which may be attributed to the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on delaying the formation of @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@fibrosis@@@ at an early stage rather than reversing the progression of @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@renal fibrosis@@@ throughout the process.", "citations": {"NLM": "Wang F, Sun H, Zuo B, Shi K, Zhang X, Zhang C, Sun D. Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy Sci Rep. 2021 Aug 11;11(1):16362. PMID: 34381133", "BibTeX": "@article{34381133, title={Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy}, author={Wang F and Sun H and Zuo B and Shi K and Zhang X and Zhang C and Sun D}, journal={Sci Rep}, volume={11}, number={1}, pages={16362}}"}}, {"_id": "38185658", "pmid": 38185658, "pmcid": "PMC10773046", "title": "Metformin and adipose-derived stem cell combination therapy alleviates radiation-induced skin fibrosis in mice", "journal": "Stem Cell Res Ther", "authors": ["Malekzadeh H", "Surucu Y", "Chinnapaka S", "Yang KS", "Arellano JA", "Samadi Y", "Epperly MW", "Greenberger JS", "Rubin JP", "Ejaz A"], "date": "2024-01-08T00:00:00Z", "doi": "10.1186/s13287-023-03627-7", "meta_date_publication": "2024 Jan 8", "meta_volume": "15", "meta_issue": "1", "meta_pages": "13", "score": 50262.23, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and adipose-derived stem cell combination therapy alleviates radiation-induced @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@skin fibrosis@@@ in mice", "citations": {"NLM": "Malekzadeh H, Surucu Y, Chinnapaka S, Yang KS, Arellano JA, Samadi Y, Epperly MW, Greenberger JS, Rubin JP, Ejaz A. Metformin and adipose-derived stem cell combination therapy alleviates radiation-induced skin fibrosis in mice Stem Cell Res Ther. 2024 Jan 8;15(1):13. PMID: 38185658", "BibTeX": "@article{38185658, title={Metformin and adipose-derived stem cell combination therapy alleviates radiation-induced skin fibrosis in mice}, author={Malekzadeh H and Surucu Y and Chinnapaka S and Yang KS and Arellano JA and Samadi Y and Epperly MW and Greenberger JS and Rubin JP and Ejaz A}, journal={Stem Cell Res Ther}, volume={15}, number={1}, pages={13}}"}}, {"_id": "33835703", "pmid": 33835703, "title": "Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.", "journal": "Int J Rheum Dis", "authors": ["Karatas A", "Celik C", "Oz B", "Akar ZA", "Etem EO", "Dagli AF", "Koca SS"], "date": "2021-06-01T00:00:00Z", "doi": "10.1111/1756-185X.14114", "meta_date_publication": "2021 Jun", "meta_volume": "24", "meta_issue": "6", "meta_pages": "795-802", "score": 50261.26, "text_hl": "@CHEMICAL_secukinumab @CHEMICAL_MESH:C555450 @@@Secukinumab@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ ameliorate dermal @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@fibrosis@@@ by decreasing tissue interleukin-17 levels in @CHEMICAL_Bleomycin @CHEMICAL_MESH:D001761 @@@bleomycin@@@-induced dermal @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@fibrosis@@@.", "citations": {"NLM": "Karatas A, Celik C, Oz B, Akar ZA, Etem EO, Dagli AF, Koca SS. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis. Int J Rheum Dis. 2021 Jun;24(6):795-802. PMID: 33835703", "BibTeX": "@article{33835703, title={Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.}, author={Karatas A and Celik C and Oz B and Akar ZA and Etem EO and Dagli AF and Koca SS}, journal={Int J Rheum Dis}, volume={24}, number={6}, pages={795-802}}"}}, {"_id": "38003450", "pmid": 38003450, "pmcid": "PMC10671059", "title": "Metformin Attenuates TGF-beta1-Induced Fibrosis in Salivary Gland: A Preliminary Study", "journal": "Int J Mol Sci", "authors": ["Wang L", "Zhong NN", "Wang X", "Peng B", "Chen Z", "Wei L", "Li B", "Li Y", "Cheng Y"], "date": "2023-11-13T00:00:00Z", "doi": "10.3390/ijms242216260", "meta_date_publication": "2023 Nov 13", "meta_volume": "24", "meta_issue": "22", "meta_pages": "", "score": 50258.78, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Attenuates @GENE_TGFB1 @GENE_7040 @@@TGF-beta1@@@-Induced @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@Fibrosis@@@ in Salivary Gland: A Preliminary Study", "citations": {"NLM": "Wang L, Zhong NN, Wang X, Peng B, Chen Z, Wei L, Li B, Li Y, Cheng Y. Metformin Attenuates TGF-beta1-Induced Fibrosis in Salivary Gland: A Preliminary Study Int J Mol Sci. 2023 Nov 13;24(22):. PMID: 38003450", "BibTeX": "@article{38003450, title={Metformin Attenuates TGF-beta1-Induced Fibrosis in Salivary Gland: A Preliminary Study}, author={Wang L and Zhong NN and Wang X and Peng B and Chen Z and Wei L and Li B and Li Y and Cheng Y}, journal={Int J Mol Sci}, volume={24}, number={22}}"}}, {"_id": "32798709", "pmid": 32798709, "title": "Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis.", "journal": "Clin Gastroenterol Hepatol", "authors": ["Kaplan DE", "Serper M", "John BV", "Tessiatore KM", "Lerer R", "Mehta R", "Fox R", "Aytaman A", "Baytarian M", "Hunt K", "Albrecht J", "Taddei TH", "Veterans Outcomes and Cost Associated with Liver disease Study Group"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.cgh.2020.08.026", "meta_date_publication": "2021 Oct", "meta_volume": "19", "meta_issue": "10", "meta_pages": "2148-2160.e14", "score": 50257.26, "text_hl": "Before the diagnosis of @<m>DISEASE_Fibrosis</m> @DISEASE_MESH:D005355 @@@cirrhosis@@@, 11,114 @SPECIES_9606 @@@patients@@@ had active utilization of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Kaplan DE, Serper M, John BV, Tessiatore KM, Lerer R, Mehta R, Fox R, Aytaman A, Baytarian M, Hunt K, Albrecht J, Taddei TH, Veterans Outcomes and Cost Associated with Liver disease Study Group. Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2148-2160.e14. PMID: 32798709", "BibTeX": "@article{32798709, title={Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis.}, author={Kaplan DE and Serper M and John BV and Tessiatore KM and Lerer R and Mehta R and Fox R and Aytaman A and Baytarian M and Hunt K and Albrecht J and Taddei TH and Veterans Outcomes and Cost Associated with Liver disease Study Group}, journal={Clin Gastroenterol Hepatol}, volume={19}, number={10}, pages={2148-2160.e14}}"}}]}